Heren Health Co Ltd Net Assets
Heren Health Co Ltd net assets. Based on the latest financial reports, Heren Health Co Ltd (300550) has net assets worth CN¥1.14 Billion CNY (≈ $167.17 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.41 Billion ≈ $206.50 Million USD) and total liabilities (CN¥268.81 Million ≈ $39.34 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset momentum of Heren Health Co Ltd to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.14 Billion |
| % of Total Assets | 80.95% |
| Annual Growth Rate | 37.7% |
| 5-Year Change | 1.46% |
| 10-Year Change | 142.31% |
| Growth Volatility | 69.38 |
Net Assets of Heren Health Co Ltd (2011–2025)
Net assets of Heren Health Co Ltd from 2011 to 2025. This chart illustrates how Heren Health Co Ltd's net assets have evolved over time, based on quarterly financial data. See net asset quality index of Heren Health Co Ltd to measure how much of total assets are equity-financed.
Annual Net Assets for Heren Health Co Ltd (2011–2025)
The table below shows the annual net assets of Heren Health Co Ltd from 2011 to 2025. For live market cap and overall valuation, see Heren Health Co Ltd stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.18 Billion ≈ $172.44 Million |
+5.25% |
| 2024-12-31 | CN¥1.12 Billion ≈ $163.85 Million |
+3.63% |
| 2023-12-31 | CN¥1.08 Billion ≈ $158.11 Million |
+3.74% |
| 2022-12-31 | CN¥1.04 Billion ≈ $152.41 Million |
-10.33% |
| 2021-12-31 | CN¥1.16 Billion ≈ $169.96 Million |
+3.24% |
| 2020-12-31 | CN¥1.13 Billion ≈ $164.63 Million |
+78.58% |
| 2019-12-31 | CN¥630.00 Million ≈ $92.19 Million |
+12.94% |
| 2018-12-31 | CN¥557.83 Million ≈ $81.63 Million |
+8.42% |
| 2017-12-31 | CN¥514.52 Million ≈ $75.29 Million |
+5.80% |
| 2016-12-31 | CN¥486.33 Million ≈ $71.17 Million |
+123.72% |
| 2015-12-31 | CN¥217.38 Million ≈ $31.81 Million |
+33.78% |
| 2014-12-31 | CN¥162.50 Million ≈ $23.78 Million |
+39.68% |
| 2013-12-31 | CN¥116.33 Million ≈ $17.02 Million |
+173.52% |
| 2012-12-31 | CN¥42.53 Million ≈ $6.22 Million |
+218.33% |
| 2011-12-31 | CN¥13.36 Million ≈ $1.96 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Heren Health Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 24083386206.0% over the analyzed period, indicating profitable operations and earnings retention.
Heren Health Co Ltd Net Assets Breakdown (December 2025)
Heren Health Co Ltd net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥240.83 Million | 20.91% |
| Other Components | CN¥910.96 Million | 79.09% |
| Total Equity | CN¥1.15 Billion | 100.00% |
Heren Health Co Ltd Competitors by Market Cap
The table below lists competitors of Heren Health Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hanjia Design Croup Co Ltd Class A
SHE:300746
|
$438.01 Million |
|
Mahindra Logistics Limited
NSE:MAHLOG
|
$438.07 Million |
|
Solaer Israel Ltd
TA:SOLR
|
$438.14 Million |
|
First Bank
NASDAQ:FRBA
|
$438.15 Million |
|
2CRSI S.A.
PA:AL2SI
|
$437.99 Million |
|
PTC India Limited
NSE:PTC
|
$437.73 Million |
|
GABIA Inc
KQ:079940
|
$437.72 Million |
|
Miquel y Costas & Miquel S.A.
MC:MCM
|
$437.60 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Heren Health Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,110,690,630 to 1,151,790,807, a change of 41,100,178 (3.7%).
- Net income of 47,664,179 contributed positively to equity growth.
- Dividend payments of 8,870,046 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥47.66 Million | +4.14% |
| Dividends Paid | CN¥8.87 Million | -0.77% |
| Other Changes | CN¥2.31 Million | +0.2% |
| Total Change | CN¥- | 3.70% |
Book Value vs Market Value Analysis
This analysis compares Heren Health Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.60x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.54x to 2.60x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | CN¥3.22 | CN¥11.40 | x |
| 2018-12-31 | CN¥3.36 | CN¥11.40 | x |
| 2019-12-31 | CN¥3.76 | CN¥11.40 | x |
| 2020-12-31 | CN¥5.77 | CN¥11.40 | x |
| 2021-12-31 | CN¥4.27 | CN¥11.40 | x |
| 2022-12-31 | CN¥3.96 | CN¥11.40 | x |
| 2023-12-31 | CN¥4.11 | CN¥11.40 | x |
| 2024-12-31 | CN¥4.23 | CN¥11.40 | x |
| 2025-12-31 | CN¥4.39 | CN¥11.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Heren Health Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.14%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.96%
- • Asset Turnover: 0.29x
- • Equity Multiplier: 1.30x
- Recent ROE (4.14%) is below the historical average (5.99%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 24.17% | 22.98% | 0.60x | 1.76x | CN¥30.32 Million |
| 2016 | 10.85% | 22.10% | 0.40x | 1.23x | CN¥4.08 Million |
| 2017 | 6.52% | 11.91% | 0.40x | 1.37x | CN¥-17.58 Million |
| 2018 | 7.39% | 10.33% | 0.41x | 1.72x | CN¥-14.28 Million |
| 2019 | 6.67% | 9.35% | 0.46x | 1.54x | CN¥-20.59 Million |
| 2020 | 3.94% | 9.49% | 0.29x | 1.43x | CN¥-66.37 Million |
| 2021 | 3.08% | 7.50% | 0.31x | 1.34x | CN¥-78.36 Million |
| 2022 | -8.01% | -23.12% | 0.25x | 1.37x | CN¥-187.32 Million |
| 2023 | 3.62% | 8.91% | 0.31x | 1.33x | CN¥-68.81 Million |
| 2024 | 3.54% | 9.68% | 0.28x | 1.32x | CN¥-71.77 Million |
| 2025 | 4.14% | 10.96% | 0.29x | 1.30x | CN¥-67.51 Million |
Industry Comparison
This section compares Heren Health Co Ltd's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $1,350,733,577
- Average return on equity (ROE) among peers: 10.85%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Heren Health Co Ltd (300550) | CN¥1.14 Billion | 24.17% | 0.24x | $438.00 Million |
| Vanfund Urban Investment & Development Co Ltd (000638) | $344.22 Million | 1.37% | 1.37x | $40.55 Million |
| Shanghai Kingstar Winning Software (300253) | $5.17 Billion | 7.31% | 0.45x | $2.17 Billion |
| Longmaster Information Tech (300288) | $986.24 Million | 9.98% | 0.22x | $463.36 Million |
| B-Soft Co Ltd (300451) | $344.85 Million | 13.80% | 0.44x | $766.20 Million |
| Yarward Electronics Shandong Co. Ltd. A (301337) | $1.15 Billion | 3.97% | 0.13x | $358.32 Million |
| Suzhou Medsys Tech Co Ltd (603990) | $108.43 Million | 28.67% | 0.80x | $870.11 Million |
About Heren Health Co Ltd
Heren Health Co.,Ltd. provides medical solutions to hospitals and governments in China. The company offers solutions to smart hospitals, healthy city, smart medical consortium, and medical treatment. Heren Health Co.,Ltd. was founded in 2010 and is headquartered in Hangzhou, China.